Design and quality considerations for randomized controlled trials in systemic sclerosis

Arthritis and Rheumatism
Maria Kyriakidi, J P Ioannidis

Abstract

To appraise systematically randomized controlled trials (RCTs) on systemic sclerosis (SSc) in order to determine whether the parameter of study design and its quality may influence the reporting of efficacy for tested interventions. Seventy RCTs were analyzed (1965-2000) in terms of design, patient characteristics, outcomes, and reported results. Median sample size was 28 patients. Fifty-nine trials were double blind, but only 16 mentioned the randomization mode and only 7 described allocation concealment. There was sufficient information on withdrawals in 37 trials. Larger trials with longer followup scored higher on quality characteristics, but had higher withdrawal rates. Only 8 trials had a followup of more than 1 year. Significant efficacy was less likely to be reported in double-blind studies (P = 0.029) and in studies with larger rates of withdrawal (P = 0.032). Specification of the following parameters improved over time: power calculations (P = 0.0003), outcomes (P = 0.001), and sample size per arm (P = 0.011). Several aspects of the quality of design and conduct of SSc RCTs can be improved. Adequately powered trials with longer followup and clear outcomes are needed.

References

Jan 1, 1992·Annals of Internal Medicine·A D Oxman, G H Guyatt
Apr 13, 1991·Lancet·P J EasterbrookD R Matthews
May 1, 1991·The American Journal of Medicine·C A ThurmR A Wise
Aug 1, 1991·Journal of Clinical Pharmacology·J C Somberg
Jan 1, 1991·Annals of the Rheumatic Diseases·M I JaysonL Taylor
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·P M Layde, S K Broste
Feb 1, 1989·The British Journal of Dermatology·J P OrtonneB Fraitag
Jan 1, 1989·Pharmacotherapy·H H ShirleyS L Spruance
Apr 1, 1988·Journal of Clinical Pharmacy and Therapeutics·S D JaniniM J Kendall
Nov 1, 1987·Journal of Clinical Pharmacology·H WollersheimA van 't Laar
Sep 1, 1986·Scandinavian Journal of Gastroenterology·L HendelP Stentoft
Jun 1, 1986·Cardiovascular Research·M AldooriP A Dieppe
Jan 1, 1985·Annals of the Rheumatic Diseases·A KahanC J Menkes
Nov 1, 1985·Annals of the Rheumatic Diseases·J S MohrlandM H Simms
May 25, 1974·Lancet·D Alarcón-SegoviaM Rojkind
May 1, 1983·European Heart Journal·A KahanM Degeorges
Nov 1, 1983·British Journal of Rheumatology·T Gibson, R Grahame
Jun 1, 1984·Annals of the Rheumatic Diseases·J F FriesP Feigenbaum
Dec 1, 1984·Journal of Behavioral Medicine·R R FreedmanP Wenig
Oct 1, 1984·Statistics in Medicine·S YusufR Peto
Jan 1, 1983·European Heart Journal·O PachingerF Kaindl
Aug 1, 1981·Annals of the Rheumatic Diseases·M F MartinJ D Kirby
Nov 8, 1995·JAMA : the Journal of the American Medical Association·K F Schulz
Aug 1, 1993·Seminars in Arthritis and Rheumatism·J E Pope, N Bellamy

❮ Previous
Next ❯

Citations

Feb 16, 2007·International Journal of Epidemiology·Dimitrios N LathyrisJohn P A Ioannidis
May 23, 2007·International Journal of Epidemiology·J PildalP C Gøtzsche
Oct 2, 2004·Annals of the Rheumatic Diseases·J P A Ioannidis
Nov 8, 2014·Spinal Cord·L A Harvey
Apr 2, 2009·Acta neurochirurgica·K SchöllerE Uhl
Apr 28, 2009·Best Practice & Research. Clinical Rheumatology·Candice EstellatPhilippe Ravaud
Nov 18, 2008·Journal of Clinical Epidemiology·Matthew E FalagasEleni Ioannidou
Jan 11, 2005·The American Journal of Medicine·John P A IoannidisHaralampos M Moutsopoulos
Jun 25, 2004·Neurosurgery·George VranosJohn P A Ioannidis
Jun 25, 2017·Neurosurgery·Tej D AzadGerald A Grant
Apr 15, 2011·The Cochrane Database of Systematic Reviews·Jan Odgaard-JensenAndrew D Oxman
Jan 31, 2006·American Journal of Epidemiology·Lise Lotte Gluud

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.